Stock A204990 KOSUN BIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Kosun Bio Co., Ltd.

Equities

A204990

KR7204990006

End-of-day quote Korea S.E.
Other stock markets
 		5-day change 1st Jan Change
- KRW -.--% Intraday chart for Kosun Bio Co., Ltd. -.--% -.--%
2020 Kosun Bio Co., Ltd. cancelled the transaction announced on September 2, 2019 CI
2020 Kosun Bio Co., Ltd. cancelled the transaction announced on December 27, 2019 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kosun Bio Co., Ltd. cancelled the transaction announced on September 2, 2019
CI
Kosun Bio Co., Ltd. cancelled the transaction announced on December 27, 2019
CI
Kosun Bio Co., Ltd. cancelled the transaction announced on September 5, 2019
CI
Kosun Bio Co., Ltd. cancelled the transaction announced on September 5, 2019
CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 5.39206 billion in funding from Macnica, Inc.
CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 1.00000044 billion in funding
CI
G2 Investment Co., Ltd. and Changkyung Jo acquired 3.13% stake in HS Vital Co., Ltd. from Korea Particle Therapy Cancer Center Co., Ltd for KRW 2 billion.
CI
Korea Particle Therapy Cancer Center Co., Ltd completed the acquisition of 31.6% in HS Vital Co., Ltd. from Jiyoon Shin.
CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 50 billion in funding from Korea Particle Therapy Cancer Center Co., Ltd
CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 50 billion in funding
CI
Korea Particle Therapy Cancer Center Co., Ltd signed a share contract to acquire 31.6% in HS Vital Co., Ltd. from Jiyoon Shin for KRW 20 billion.
CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 17.306 billion in funding from Korea Particle Therapy Cancer Center Co., Ltd
CI
HS Vital Co., Ltd. completed the acquisition of Afull Co., Ltd. from Ji-Yoon Shin and others.
CI
HS Vital Co., Ltd. agreed to acquire Afull Co., Ltd. for KRW 74.7 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A204990 Stock
  4. News Kosun Bio Co., Ltd.